TWX – Time Warner Inc is a media and entertainment company in the U.S.
|
TWX – Time Warner Inc |
||
| Fundamentals | Previously closed at | 73.64 |
| Day’s high | 74.83 | |
| Day’s low | 73.44 | |
| P/E ratio | 15.92 | |
| EPS | 4.63 | |
| Analysts opinion | TWX announced its Q1 revenues today pre-market, post which the stock prices were up by 2%. It posted an EPS at $1.49, beating the wall street estimates by $0.19. Its net sales were in line with wall street expectations at $73 Billion. Revenues were backed by HBO segment, which jumped 7.7% yoy, the movies – “Batman vs Superman”, “American Sniper” and “The Hobbit: Battle of the Five Armies.” The election season and Basketball seems to have been positive factors for TWX. |
| Also, TWX news has it that it would launch an online movie subscription platform “FilmStruck” later this year, which may be a competitor for Netflix and Hulu. FilmStruck is said to offer access to the complete Criterion movie collection to its subscribers. It also has an increased focus on China. TWX, along with RatPac Entertainment (co owned by producer Brett Ratner) and China Media Capital intend to start a local Chinese fund to invest in Chinese movies. | |
| Sentiments | Sentiments for the stock are bullish, with a jump of 2% pre-market |
| Social Media Pulse | The stock has 50% higher chatter than usual. |
RDHL – Redhill Biopharma Ltd is focused on the development of orally administered drugs for inflammatory and gastrointestinal diseases including gastrointestinal cancers.
|
RHDL – Redhill Biopharma Ltd |
||
| Fundamentals | Previously closed at | 21.51 |
| Day’s high | 12.50 | |
| Day’s low | 12.50 | |
| P/E ratio | 6.58 | |
| EPS | 1.90 | |
| Analyst opinion | The U.S. National Cancer Institute (NCI) awarded a grant of $1.8 Million to the Medical University of South Carolina to support research on a variety of solid tumor cancers, which will in turn fund RHDL’s “Yeliva”, a phase-2 clinical trial drug. For the Q1 Revenue results, RHDL had previously announced an EPS of (0.04), above analyst expectations of (0.51). The analyst confidence meter is 100% bullish according to Stockal proprietary algorithm. |
| Sentiments | Investor sentiments are bullish due to NCI’s grant. |
| Social Media Pulse | The stock has 66% higher social chatter than usual. |
Disclaimer: This blog contains an aggregated view of analysts and opinions by the author. Do not consider this as financial advice. See http://stockal.com/legalities/
